Kennedy Investment Group Karyopharm Therapeutics Inc. Transaction History
Kennedy Investment Group
- $197 Billion
- Q2 2024
A detailed history of Kennedy Investment Group transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Kennedy Investment Group holds 35,000 shares of KPTI stock, worth $29,050. This represents 0.02% of its overall portfolio holdings.
Number of Shares
35,000
Previous 35,000
-0.0%
Holding current value
$29,050
Previous $52.9 Million
42.54%
% of portfolio
0.02%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding KPTI
# of Institutions
120Shares Held
64.9MCall Options Held
500KPut Options Held
99K-
Vanguard Group Inc Valley Forge, PA7.65MShares$6.35 Million0.0% of portfolio
-
Palo Alto Investors LP Palo Alto, CA5.1MShares$4.23 Million0.56% of portfolio
-
Eversept Partners, LP New York, NY4.99MShares$4.14 Million0.33% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.32MShares$3.59 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.17MShares$3.46 Million0.0% of portfolio
About Karyopharm Therapeutics Inc.
- Ticker KPTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,806,600
- Market Cap $66.2M
- Description
- Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...